These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10532651)

  • 1. Differential neutralizing antibody responses to varicella-zoster virus glycoproteins B and E following naked DNA immunization.
    Massaer M; Haumont M; Garcia L; Mazzu L; Bollen A; Jacobs P; Jacquet A
    Viral Immunol; 1999; 12(3):227-36. PubMed ID: 10532651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
    Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
    Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
    Hasan UA; Harper DR; Wren BW; Morrow WJ
    Vaccine; 2002 Jan; 20(9-10):1308-15. PubMed ID: 11818149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
    Hasan UA; Harper DR; Argent S; Layton G; Wren BW; Morrow WJ
    Vaccine; 2000 Feb; 18(15):1506-14. PubMed ID: 10618548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J; Kutinová L; Smahel M; Nĕmecková S
    Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
    Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
    J Virol; 2021 May; 95(12):. PubMed ID: 33762414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus.
    Wang H; Zhang S; Xue W; Zeng Y; Liu L; Cui L; Liu H; Zhang Y; Chen L; Nie M; Zhang R; Chen Z; Hong C; Zheng Q; Cheng T; Gu Y; Li T; Xia N; Li S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
    Schuh T; Schultz J; Moelling K; Pavlovic J
    Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.
    Konishi E; Yamaoka M; Khin-Sane-Win ; Kurane I; Takada K; Mason PW
    J Virol; 1999 Jul; 73(7):5527-34. PubMed ID: 10364301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.
    Abendroth A; Slobedman B; Springer ML; Blau HM; Arvin AM
    Antiviral Res; 1999 Dec; 44(3):179-92. PubMed ID: 10651069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
    Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
    Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
    Fló J
    Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques.
    Loomis-Huff JE; Eberle R; Lockridge KM; Rhodes G; Barry PA
    Vaccine; 2001 Sep; 19(32):4865-73. PubMed ID: 11535340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice.
    Li D; Bian L; Cui L; Zhou J; Li G; Zhao X; Xing L; Cui J; Sun B; Jiang C; Kong W; Zhang Y; Chen Y
    Int J Nanomedicine; 2024; 19():8029-8042. PubMed ID: 39130684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization.
    Fournillier A; Depla E; Karayiannis P; Vidalin O; Maertens G; Trépo C; Inchauspé G
    J Virol; 1999 Sep; 73(9):7497-504. PubMed ID: 10438839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization.
    Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E
    Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
    Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
    J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.